Fresh Tracks Therapeutics, Inc.
FRTXDelisted Dec 27, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000819050
Fresh Tracks Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Jun 11, 2024; 15 institutions reported holding it in 13F filings for Q3 2023, worth $455.8K in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Fresh Tracks Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- 0 vs. Q2 2023
- Shares held
- 470.1K
- +370.9K (+374.3%) vs. Q2 2023
- Total value
- $455.8K
- +$386.0K (+552.7%) vs. Q2 2023
- New holders
- 4
- 3 more added
- Sold out
- 4
- 1 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $40 |
| Q4 2023 | 1 | $1.00K |
| Q3 2023 | 15 | $455.8K |
| Q2 2023 | 15 | $69.8K |
| Q1 2023 | 18 | $97.3K |
| Q4 2022 | 16 | $224.1K |
| Q3 2022 | 17 | $328.0K |
| Q2 2022 | 25 | $898.9K |
| Q1 2022 | 25 | $2.44M |
| Q4 2021 | 34 | $2.69M |
| Q3 2021 | 30 | $5.53M |
| Q2 2021 | 35 | $7.15M |
| Q1 2021 | 32 | $6.08M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Fresh Tracks Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JBF Capital, Inc. | 295,000 | $286.1K | 0.06% | +295,000 | New |
| GTS Securities LLC | 50,100 | $48.6K | 0.00% | +50,100 | New |
| Virtu Financial LLC | 43,558 | $42.0K | 0.00% | +30,716+239.2% | Added |
| Geode Capital Management, LLC | 41,449 | $40.2K | 0.00% | +26,801+183.0% | Added |
| Vanguard Group Inc | 23,060 | $22.4K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 10,224 | $9.92K | 0.00% | −254−2.4% | Reduced |
| BlackRock Inc. | 4,790 | $4.65K | 0.00% | 00.0% | Unchanged |
| Ronald Blue Trust, Inc. | 916 | $1.00K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 709 | $688 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 154 | $150 | 0.00% | +11+7.7% | Added |
| Advisor Group Holdings, Inc. | 43 | $42 | 0.00% | 00.0% | Unchanged |
| JFS Wealth Advisors, LLC | 22 | $22 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 13 | $13 | 0.00% | +13 | New |
| Northwestern Mutual Wealth Management Co | 11 | $11 | 0.00% | +11 | New |
| Royal Bank of Canada | 6 | $0 | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,328−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −10,125−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −2−100.0% | Sold out |